Homocystéine et génotypage de l'apolipoprotéine E

Revue Francophone des Laboratoires - Tập 2007 - Trang 25-29 - 2007
Mohamed Makrelouf1, Amel Otmane1, Myriam Bendib2, Mohamed Izem3, Malika Boucelma4, Akila Zenati1
1Laboratoire central de biologie
2Service de Neurologie
3Centre de tri
4Service de médecine interne Centre hospitalo-universitaire de Bab-El-Oued 06, bd Said-Touati - Bab El Oued Alger- 16000 - Algérie

Tài liệu tham khảo

Buysschaert, 2000, Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy and insulin resistance, Diabetes Care, 12, 1816, 10.2337/diacare.23.12.1816 Chartier-Harlin, 1994, Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region, Hum. Mol. Genet., 3, 569, 10.1093/hmg/3.4.569 Christen, 2000, Blood levels of homocysteine and increased risks of cardiovascular disease, Arch. Intern. Med., 160, 422, 10.1001/archinte.160.4.422 Clarke, 1991, Hyperhomocysteinemia: an independant risk factor for vascular disease, N. Engl. J. Med., 324, 1149, 10.1056/NEJM199104253241701 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Cumming, 1984, Polymorphism at the apoprotein-E locus in relation to risk of coronary disease, Clin. Genet., 25, 310, 10.1111/j.1399-0004.1984.tb01995.x Dallongeville, 1993, Apolipoprotéine E : propriétés physiologiques polymorphisme et athérosclérose, Sang Thromb. Vais., 5, 707 Davignon, 1991, Apolipoprotein E polymorphism, dyslipidemia and atherosclerosis, Nutr. Metab. Cardiovasc. Dis., 1, 53 Davignon, 1988, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8, 1, 10.1161/01.ATV.8.1.1 Dussoix, 1996, Facteurs de risque génétique de maladie cardio-vasculaire, Med. Hyg., 54, 528 Galton, 1997, Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications, Clin. Chim. Acta., 257, 181, 10.1016/S0009-8981(96)06443-1 Henderson, 1995, Apolipoprotein E allele e4, dementia, and cognitive decline in a population sample, Lancet, 346, 1387, 10.1016/S0140-6736(95)92405-1 Homocysteine Lowering Trial, 1998, Lowering blood homocysteine with folic acid based supplements: meta-analysis, Br. Med. J., 316, 894, 10.1136/bmj.316.7135.894 Kaare, 2006, Homocysteine lowering and cardiovascular events after acute myocardial infarction, N. Engl. J. Med., 354, 1578, 10.1056/NEJMoa055227 Lahlali-Kacemi, 2002, Polymorphisme de l'apolipoprotéine E dans une population marocaine : fréquence allélique et relation avec les paramètres lipidiques plasmatiques, Ann. Biol. Clin., 60, 73 Lahoz, 2001, Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study, Ath., 154, 529, 10.1016/S0021-9150(00)00570-0 Moore, 1997, The role of the apolipoprotein E polymorphism in the prediction of coronary artery disease age of onset, Clin. Genet., 51, 22, 10.1111/j.1399-0004.1997.tb02408.x Poirier, 1993, Apolipoprotein E polymorphism and Alzheimer's disease, Lancet, 342, 697, 10.1016/0140-6736(93)91705-Q Ray, 1999, Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review, Placenta, 20, 519, 10.1053/plac.1999.0417 Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, JAMA, 270, 2693, 10.1001/jama.1993.03510220049033 Seshadri, 2002, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N. Engl. J. Med., 34, 476, 10.1056/NEJMoa011613 Smith, 2002, Homocysteine, B vitamins, and cognitive deficit in the elderly, Am. J. Clin. Nutr., 75, 785, 10.1093/ajcn/75.5.785 Stampfer, 1992, A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians, JAMA, 268, 877, 10.1001/jama.1992.03490070059042 Vollset, 2000, Plasma total homocysteine, pregnancy complications, and adverse outcomes: the Hordaland homocysteine study, Am. J. Clin. Nutr., 71, 962, 10.1093/ajcn/71.4.962 Weisgraber, 1996, Human apolipoprotein E: the Alzheimer's disease connection, FASEB, 10, 1485, 10.1096/fasebj.10.13.8940294 Welch, 1997, Hyperhomocysteinemia and atherothrombosis, Ann. NY Acad. Sci., 811, 48, 10.1111/j.1749-6632.1997.tb51988.x Willson, 1996, Apo E alleles and risk of coronary desease, A meta analysis, Artherioscler. Thromb. Vasc. Biol., 10, 1250, 10.1161/01.ATV.16.10.1250